Slowing down Alzheimer’s disease: what really works now?
Professor Naji Tabet
Thursday 8 May at 6.30pm
Chowen Lecture TheatreBSMS Teaching BuildingUniversity of Sussex, FalmerBrighton, BN1 9PX
Book your place
Recent years have seen major advances in the diagnosis and treatment of Alzheimer’s disease.
New guidelines, not fully implemented yet, call for a move away from a ‘clinically’ based diagnosis to one centred on biomarkers. Specific antibodies have been identified as having the potential to significantly change management of Alzheimer’s disease in this fast-moving field.
Targeting risk factors may prevent some cases, but much less is established about managing these in people who already have the disease. A combination of disease modifying and symptomatic medication alongside non-pharmacological interventions may offer the best hope for treating patients currently.
Further research will identify more approaches that can truly revolutionise the treatment of Alzheimer’s disease. For now, understanding what is already available and how to utilise it effectively offer the best hope to people living with Alzheimer’s disease.
Free event. All are welcome. If you would like to attend, please register online no later than 48 hours prior to the event.
TEF Silver awarded for the quality of our teaching and student outcomes
We are in the top 4.3% of institutions globally, Center for World University Rankings 2025
Race Equality Charter Silver awarded for our pledge to advance representation, progression and success for minority ethnic staff and students
We are ranked 14th in Stonewall's top 100 employers for commitment to equality for LGBTQ+ staff and students
We were awarded Athena Swan Silver for advancement of gender equality, representation, progression and success for all
We are a Disability Confident employer, committed to ensuring opportunity for progression for all
Signed to the Disabled Student Commitment, an initiative to improve support for disabled students
EcoCampus Platinum accredited for our environmental sustainability, compliance and processes